We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SOPA:NASDAQSociety Pass Incorporated Analysis

Data as of 2026-05-26 - not real-time

$0.08

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Society Pass Inc. (SOPA) is trading at $0.076, well below its 20‑day SMA of $0.294 and 50‑day SMA of $0.419, indicating a deep downtrend. The 14‑day RSI sits at 17.8, signaling extreme oversold conditions, while the MACD line (-0.107) is beneath the signal line (-0.083), confirming bearish momentum. Volatility is sky‑high at 327% over the past 30 days and beta exceeds 2.5, implying the stock moves dramatically more than the market. Fundamental metrics are equally troubling: the company reports negative operating margin (-3.8%) and a trailing EPS of -$2.50, resulting in a meaningless PE ratio and a price‑to‑book of only 0.03. Cash burn is severe, with operating cash flow of -$18.9 M and free cash flow of -$8.0 M, while debt‑to‑equity sits at 7.2, reflecting a heavily leveraged balance sheet. Moreover, on May 12 2026 the firm filed for Chapter 11 bankruptcy and Nasdaq has issued a delisting notice, triggering a 21% after‑hours price drop.
These catalysts combine with an “Extreme Greed” market sentiment (Fear‑Greed Index 91) to create a speculative rally that is unlikely to be sustainable given the company’s distressed fundamentals. The upside‑downside metric shows an apparent 27,860% upside, but this is driven by a near‑zero price floor rather than genuine growth potential. With a max drawdown of –99.2% and a market cap under $1 M, liquidity is thin and any further negative news could wipe out remaining value. Consequently, the stock is judged to be overvalued relative to its intrinsic distressed value, aligns more with a value‑style assessment, and offers no dividend sustainability. Investors should view SOPA as a high‑risk, short‑term play rather than a long‑term holding.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 9/10

Key Factors

  • Nasdaq delisting notice following Chapter 11 filing
  • Bearish technical indicators (RSI 17.8, MACD bearish, price below all SMAs)
  • Extreme volatility and high beta amplifying downside risk

Medium Term

1–3 years
Cautious
Model confidence: 8/10

Key Factors

  • Ongoing restructuring uncertainty and negative cash flows
  • Persistent negative earnings and margins
  • Thin liquidity and near‑zero market capitalization

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside if restructuring succeeds and debt is reduced
  • Current price offers a deep discount to book value
  • High risk of complete loss due to bankruptcy and delisting

Key Metrics & Analysis

Financial Health

Revenue Growth-17.60%
Profit Margin-146.00%
P/E Ratio-0.4
ROE-153.37%
ROA-25.95%
Debt/Equity7.22
P/B Ratio0.0
Op. Cash Flow$-18869904
Free Cash Flow$-8043035
Industry P/E17.0

Technical Analysis

TrendBearish
RSI17.8
Support$0.03
Resistance$0.47
MA 20$0.29
MA 50$0.42
MA 200$1.39
MACDBearish
VolumeIncreasing
Fear & Greed Index91.38

Valuation

Target Price$21.25
Upside/Downside27860.53%
GradeOvervalued
TypeValue

Risk Assessment

Beta2.52
Volatility327.26%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.